COVID Alert has returned to the spotlight after fresh Maharashtra COVID cases were reported nearly three years after infections remained low.
A recent drug recall involving oncology products has once again brought global pharmaceutical quality standards into focus, recalls are not necessarily indicators of systemic failure but rather evidence of active monitoring and corrective mechanisms
Cadila Rejects Aciloc Ban Reports has become the latest talking point after the company issued a detailed clarification.
Covid precautions have returned to focus after Andhra Pradesh reported two Covid deaths and eight active Covid cases.
COVID preparedness has become a key focus in Odisha after fresh COVID-19 cases were reported in neighboring Andhra Pradesh.
India's Breast Cancer Survival Rate is improving, offering hope to thousands of women. However, the country still trails many high-income nations. A new World Health Organization (WHO) report shows that India's five-year survival rate has reached...
The Ebola concern in the Democratic Republic of the Congo has entered a new phase. Health officials are now focusing less on the official case count.
The government has proposed bringing several alcohol-based medicinal products under Schedule H1. The move aims to prevent misuse while ensuring patients continue to access genuine treatment.
The Central Drugs Standard Control Organization (CDSCO) is tightening its focus on patient safety, which includes renewed efforts to eliminate irrational drug combinations
The Dr. Reddy's semaglutide delay has raised questions about the company's plans in one of the fastest-growing drug markets.
.jpg)
, CDSCO.jpg)